Cancer has typically been treated by either radiation, surgery, drugs. But Novocure (NASDAQ: NVCR) has developed a fourth paradigm, tumor treating fields, which can inhibit the growth of tumors by inhibiting tumor cell division. In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com Contributor Brian Orelli discuss how the treatments work and the potential data readouts that Novocure will experience in 2021.
For further details see:
Investors Take Note: This Biotech Stock Has Multiple Readouts in 2021